News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Illumina, Inc. Announces Scale-Up of Genome Analyzers at The Broad Institute
November 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Illumina, Inc.
MORE ON THIS TOPIC
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
October 23, 2025
·
74 min read
·
BioSpace Editorial Staff
Earnings
MASH, Metsera Deals Send Analysts Marauding to Viking
October 23, 2025
·
6 min read
·
Annalee Armstrong
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
October 23, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody
October 22, 2025
·
1 min read
·
Dan Samorodnitsky
